FCMV
Foresite Capital Management VI Portfolio holdings
AUM
$178M
1 Year Est. Return
–
AUM
$183M
AUM Growth
-$41.9M
(-19%)
Holding
14
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CG Oncology
CGON
$3.38B
| $54.4M | 29.8% |
2,221,474
|
|
||
|
ALMS
2
Alumis Inc
ALMS
$501M
| $25.8M | 14.14% |
4,202,670
|
|
||
|
CNTA
3
Centessa Pharmaceuticals
CNTA
$3.28B
| $18M | 9.87% |
1,253,379
|
|
||
4
RAPT Therapeutics
RAPT
$749M
| $15.3M | 8.35% |
1,562,500
|
|
||
5
Akero Therapeutics
AKRO
$4.32B
| $14.8M | 8.09% |
365,000
|
|
||
6
Edgewise Therapeutics
EWTX
$1.69B
| $12.9M | 7.05% |
585,000
|
|
||
|
BCAX
7
Bicara Therapeutics
BCAX
$928M
| $12.4M | 6.78% |
950,000
|
|
||
8
Structure Therapeutics
GPCR
$1.65B
| $7.27M | 3.98% |
420,000
|
|
||
9
Allogene Therapeutics
ALLO
$273M
| $5.03M | 2.76% |
3,448,275
|
|
||
10
Corvus Pharmaceuticals
CRVS
$586M
| $5.03M | 2.75% |
1,581,233
|
|
||
11
Cullinan Oncology
CGEM
$476M
| $4.8M | 2.63% |
634,558
|
|
||
12
Kymera Therapeutics
KYMR
$4.35B
| $4.01M | 2.19% |
146,332
|
|
||
13
CASI Pharmaceuticals
CASI
$25.1M
| $2.87M | 1.57% |
1,329,383
|
|
||
14
Viridian Therapeutics
VRDN
$2.1B
| $26.6K | 0.01% |
1,974
|
|